Neurocrine Biosciences Inc (NASDAQ:NBIX)
| 98.10 BATS BZX Real-Time Price As of 2:59pm ET |  -1.11 / -1.12%Today’s Change | 71.88 Today|||52-Week Range 108.02 | +15.18% Year-to-Date |
Latest NBIX News | Press Releases
No recent news for Neurocrine Biosciences Inc.
Today’s Trading
| Previous close | 99.21 |
| Today’s open | 98.87 |
| Day’s range | 97.67 - 99.59 |
| Volume | 16,183 |
| Average volume (3 months) | 730,056 |
| Market cap | $9.5B |
Data as of 2:59pm ET, 07/05/2022
Growth & Valuation
| Earnings growth (last year) | -78.35% |
| Earnings growth (this year) | +132.04% |
| Earnings growth (next 5 years) | +40.62% |
| Revenue growth (last year) | +8.38% |
| P/E ratio | 134.4 |
| Price/Sales | 7.36 |
| Price/Book | 6.84 |
Competitors
Data as of 2:59pm ET, 07/05/2022
Financials
| Next reporting date | August 2, 2022 |
| EPS forecast (this quarter) | $0.61 |
| Annual revenue (last year) | $1.1B |
| Annual profit (last year) | $89.6M |
| Net profit margin | 7.90% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
